Loading…
Tiger Vapes manufactured and distributed e-liquid tobacco products without obtaining required premarket authorization from the FDA, in violation of the Family Smoking Prevention and Tobacco Control Act. The company's e-liquid products met the definition of newly deemed tobacco products subject to FDA jurisdiction as of August 8, 2016, and were required to have marketing authorization orders under section 910 of the Federal Food, Drug, and Cosmetic Act before commercial distribution. The FDA's inspection records and review of the company's submissions revealed that Tiger Vapes failed to secure this premarket approval prior to offering the products for sale in the United States.